Syndax Pharmaceuticals, Inc. (SNDX) stock analysis
SNDX · Syndax Pharmaceuticals, Inc.
Latest recorded price: USD 9.13
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 7.3%, free cash flow margin -187.5%. The model flags 1 risk signal for this company (1 high severity).